Healthcare Informatics January 6, 2018
Mark Hagland

The news during the last week of October that the mega-pharmacy retailer CVS was in talks to acquire the Hartford, Conn.-based Aetna—a deal that is now moving ahead, as documented in a December 4 announcement of the deal—has created waves of interest, and even discombobulation, across the various segments of U.S. healthcare, from the pharmaceutical manufacturing sector, to the retail pharmacy sector to the pharmacy benefit management sector, to the health plan sector, to the physician practice sector.

The talk of the potential for industry disruption has continued since the first reports of the deal in October, and for good reason: deals like the pending CVS-Aetna agreement do tend to disrupt the existing dynamics in any sector within healthcare that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Mergers & Acquisitions / JV, Payer, Retail care
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Weekly HCRE Briefing: AdventHealth to Acquire Two CHS Hospitals in FL | Kaiser Acquiring ASCs and MOBs

Share This Article